Scoop has an Ethical Paywall
Work smarter with a Pro licence Learn More

Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Metlifecare likely to see share price surge

Metlifecare likely to see share price surge, says First NZ Capital

By Fiona Rotherham

May 5 (BusinessDesk) - Analysts are picking a likely upsurge in the share price of retirement village operator Metlifecare in coming months due to a ramp-up in development, change in leadership, and supportive conditions, despite the company having traded at a discount relative to its industry peers over the past decade.

Metlifecare delivered net profit of $125.7 million in the first half of 2016, more than three times higher than the previous year, mainly due to a lift in list prices for resale units in Auckland and Bay of Plenty. It is one of the country’s largest providers with 25 retirement villages throughout the North Island and $2.4 billion in assets.

The appointment of a new chief executive, former head of Housing New Zealand Glen Sowry, who took over the reins in April, could lead to accelerated development rather than traditionally lagging, said First NZ Capital analysts in a research note.

“We see potential for a well-communicated development strategy to be well received by the market. Given the circumstances, we believe some re-rating could occur prior to actual execution."

Sowry's three years at HNZ could translate well to what the analysts call Metlifecare’s “lowest hanging fruit – namely development expansion”.

“We see MET’s pipeline of build as more attractive than it has been for many years and we expect new management over time to accelerate both the build programme and also site purchases,” they said.

Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

Metlifecare shares are currently trading at $5.39, up 10 percent in the past year, compared to $8.98 for competitor Ryman and $4.36 for Summerset. First NZ has a target price on Metlifecare of $5.45 to $5.90 per share.

Metlifecare has traded close to net tangible assets per share over the past 15 years rather than at a multiple of NTA as rivals Ryman and Summerset do. Although the operator’s valuation discount to its peers has improved in recent months, the analysts expect it to narrow further to closer to Summerset.

Some NTA uplift is already ‘locked in’ due to the unit price increases already booked in the first half and supportive house price inflation in the first quarter of 2016, with Metlifecare having the most advantaged exposure to the housing market of the listed retirement operators due to having more assets in Auckland and Tauranga, the analysts said.

It’s due to report its full-year results in August and First NZ is forecasting a full-year net profit of $212 million, compared to $123 million in 2015.

First NZ said it wouldn’t rule out Metlifecare’s cornerstone shareholders, Infratil and NZ Super who both hold just under 20 percent, increasing their stakes given the long-term investment horizon.

(BusinessDesk)

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Business Headlines | Sci-Tech Headlines

 
 
 
 
 
 
 
 
 
 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.